| P2093 | author name string | Qing Lu | |
| | Li Li | |
| | Bin Zhao | |
| | Chen-Ying Liu | |
| | Kun-Liang Guan | |
| | Lloyd H Wang | |
| | Qunying Lei | |
| P2860 | cites work | Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation | Q24290939 |
| | A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP) | Q24293710 |
| | Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control | Q24299106 |
| | Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation | Q24300596 |
| | Tumor suppressor LATS1 is a negative regulator of oncogene YAP | Q24304725 |
| | TEAD mediates YAP-dependent gene induction and growth control | Q24336045 |
| | Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 |
| | Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. | Q52015849 |
| | The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. | Q52100108 |
| | Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. | Q52704046 |
| | Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway | Q81088455 |
| | The human tumour suppressor LATS1 is activated by human MOB1 at the membrane | Q83287887 |
| | Expression of Yes-associated protein in common solid tumors | Q24657592 |
| | Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon | Q24682018 |
| | The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 | Q28116287 |
| | Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains | Q28212001 |
| | salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines | Q28219379 |
| | A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells | Q28238594 |
| | The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP | Q28266862 |
| | The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version | Q28281214 |
| | Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP) | Q28287783 |
| | Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein | Q28306685 |
| | YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation | Q28507494 |
| | Angiomotin regulates visceral endoderm movements during mouse embryogenesis | Q28587014 |
| | Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression | Q28591557 |
| | YAP1 increases organ size and expands undifferentiated progenitor cells | Q28592519 |
| | Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded | Q28752559 |
| | Elucidation of a universal size-control mechanism in Drosophila and mammals | Q29618935 |
| | The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis | Q29619851 |
| | hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts | Q29620457 |
| | Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma | Q33611696 |
| | YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway | Q33644875 |
| | The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded | Q33934781 |
| | Control of cell proliferation and apoptosis by mob as tumor suppressor, mats | Q34402685 |
| | p130-angiomotin associates to actin and controls endothelial cell shape | Q34517933 |
| | The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila | Q34559232 |
| | The bantam microRNA is a target of the hippo tumor-suppressor pathway | Q34562924 |
| | Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells | Q34731285 |
| | The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis | Q36336754 |
| | Multiple microalterations detected at high frequency in oral cancer | Q38441119 |
| | Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines | Q39827808 |
| | The FERM-domain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie | Q39872336 |
| | A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells | Q39991840 |
| | Characterization of the interface between normal and transformed epithelial cells | Q42450915 |
| | Phosphorylation-independent repression of Yorkie in Fat-Hippo signaling. | Q42625092 |
| | Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway | Q44591663 |
| | Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. | Q46433336 |
| | Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila | Q47072038 |
| | Mob as tumor suppressor is activated at the cell membrane to control tissue growth and organ size in Drosophila | Q47072497 |
| | Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. | Q48364922 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Angiomotin | Q4763281 |
| | hippo signaling | Q5768379 |
| | Angiomotin-like 1 | Q21981186 |
| P304 | page(s) | 51-63 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Genes & Development | Q1524533 |
| P1476 | title | Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein | |
| P478 | volume | 25 | |